Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 11-Mar-22 4:22 PM View:  | Schoch Steven J Director | Arena Pharmaceuticals, Inc. (ARNA) | 11-Mar-22 | Disposition (other) | 4,600 | -- | -- | (100%) 4.6K to 0 | |
| 11-Mar-22 4:12 PM View: | Manion Douglas J. EVP Research & Development | Arena Pharmaceuticals, Inc. (ARNA) | 11-Mar-22 | Disposition (other) | 36,462 | -- | -- | (100%) 36.46K to 0 | |
| 11-Mar-22 4:24 PM View: | Nova Tina Susan Director | Arena Pharmaceuticals, Inc. (ARNA) | 11-Mar-22 | Disposition (other) | 20,843 | -- | -- | (100%) 20.84K to 0 | |
| 11-Mar-22 4:22 PM View: | Dallas Jayson Donald Alexan... Director | Arena Pharmaceuticals, Inc. (ARNA) | 11-Mar-22 | Disposition (other) | 7,152 | -- | -- | (100%) 7.15K to 0 | |
| 11-Mar-22 4:23 PM View: | Knobil Katharine Director | Arena Pharmaceuticals, Inc. (ARNA) | 11-Mar-22 | Disposition (other) | 6,821 | -- | -- | (100%) 6.82K to 0 | |
| 11-Mar-22 4:21 PM View: | Ouzren Nawal Director | Arena Pharmaceuticals, Inc. (ARNA) | 11-Mar-22 | Disposition (other) | 4,555 | -- | -- | (100%) 4.55K to 0 | |
| 11-Mar-22 4:23 PM View: | Jarrett Jennifer Director | Arena Pharmaceuticals, Inc. (ARNA) | 11-Mar-22 | Disposition (other) | 11,217 | -- | -- | (100%) 11.22K to 0 | |
| 11-Mar-22 4:11 PM View: | Munshi Amit President and CEO Director | Arena Pharmaceuticals, Inc. (ARNA) | 11-Mar-22 | Disposition (other) | 114,897 | -- | -- | (100%) 114.9K to 0 | |
| 11-Mar-22 4:23 PM View: | Gallahue Kieran Director | Arena Pharmaceuticals, Inc. (ARNA) | 11-Mar-22 | Disposition (other) | 3,628 | -- | -- | (28%) 12.91K to 9.28K | |
| 11-Mar-22 4:12 PM View: | Stelzer Laurie EVP & Chief Financial Officer | Arena Pharmaceuticals, Inc. (ARNA) | 11-Mar-22 | Disposition (other) | 37,208 | -- | -- | (100%) 37.21K to 0 | |
| 11-Mar-22 4:07 PM View: | Vincent Aurentz Executive VP and CBO | Arena Pharmaceuticals, Inc. (ARNA) | 11-Mar-22 | Disposition (other) | 55,964 | -- | -- | (100%) 55.96K to 0 | |
| 11-Mar-22 4:24 PM View: | Fetzer Oliver Director | Arena Pharmaceuticals, Inc. (ARNA) | 11-Mar-22 | Disposition (other) | 9,692 | -- | -- | (100%) 9.69K to 0 | |
| 11-Mar-22 4:06 PM View: | Lisicki Robert EVP, Chief Commercial Officer | Arena Pharmaceuticals, Inc. (ARNA) | 11-Mar-22 | Disposition (other) | 37,563 | -- | -- | (100%) 37.56K to 0 | |
| 11-Mar-22 4:22 PM View: | Neil Garry Arthur Director | Arena Pharmaceuticals, Inc. (ARNA) | 11-Mar-22 | Disposition (other) | 11,217 | -- | -- | (100%) 11.22K to 0 | |
| 11-Mar-22 4:09 PM View: | Schmidt Joan EVP, General Counsel & Sec | Arena Pharmaceuticals, Inc. (ARNA) | 11-Mar-22 | Disposition (other) | 36,287 | -- | -- | (100%) 36.29K to 0 | |
| 11-Mar-22 4:23 PM View: | Gallahue Kieran Director | Arena Pharmaceuticals, Inc. (ARNA) | 11-Mar-22 | Disposition (other) | 9,283 | -- | -- | (100%) 9.28K to 0 | |
| 11-Mar-22 4:11 PM View: | Munshi Amit President and CEO Director | Arena Pharmaceuticals, Inc. (ARNA) | 08-Mar-22 | Gift | 10,500 | $98.51 | $1,034,360.00 | (8%) 125.4K to 114.9K | |
| 05-Jan-22 5:02 PM View: | Schmidt Joan EVP, General Counsel & Sec | Arena Pharmaceuticals, Inc. (ARNA) | 03-Jan-22 | Grant | 21,462 | -- | -- | 147% 14.6K to 36.06K | |
| 05-Jan-22 4:59 PM View: | Vincent Aurentz Executive VP and CBO | Arena Pharmaceuticals, Inc. (ARNA) | 03-Jan-22 | Grant | 21,462 | -- | -- | 64% 33.66K to 55.12K | |
| 05-Jan-22 5:00 PM View: | Lisicki Robert EVP, Chief Commercial Officer | Arena Pharmaceuticals, Inc. (ARNA) | 03-Jan-22 | Grant | 21,462 | -- | -- | 133% 16.1K to 37.56K | |
| 05-Jan-22 5:02 PM View: | Manion Douglas J. EVP Research & Development | Arena Pharmaceuticals, Inc. (ARNA) | 03-Jan-22 | Grant | 21,462 | -- | -- | 143% 15.0K to 36.46K | |
| 05-Jan-22 10:00 PM View: | Munshi Amit President and CEO Director | Arena Pharmaceuticals, Inc. (ARNA) | 03-Jan-22 | Grant | 85,847 | -- | -- | 217% 39.55K to 125.4K | |
| 05-Jan-22 10:00 PM View: | Stelzer Laurie EVP & Chief Financial Officer | Arena Pharmaceuticals, Inc. (ARNA) | 03-Jan-22 | Grant | 21,462 | -- | -- | 144% 14.9K to 36.37K | |
| 17-Aug-21 8:30 AM View: | Munshi Amit President and CEO Director | Arena Pharmaceuticals, Inc. (ARNA) | 16-Aug-21 | Market Purchase | 1,000 | $48.19 | $48,190.00 | 3% 38.55K to 39.55K | (< 1%) |
| 17-Aug-21 8:30 AM View: | Manion Douglas J. EVP Research & Development | Arena Pharmaceuticals, Inc. (ARNA) | 15-Aug-21 | Grant | 15,000 | -- | -- | 100% 0 to 15.0K | |
| 13-Aug-21 8:10 AM View: | Munshi Amit President and CEO Director | Arena Pharmaceuticals, Inc. (ARNA) | 12-Aug-21 | Market Purchase | 1,000 | $50.41 | $50,410.00 | 3% 37.55K to 38.55K | (2%) |
| 11-Aug-21 8:04 AM View: | Munshi Amit President and CEO Director | Arena Pharmaceuticals, Inc. (ARNA) | 10-Aug-21 | Market Purchase | 1,000 | $52.92 | $52,915.00 | 3% 36.55K to 37.55K | (3%) |
| 05-Aug-21 6:08 PM View: | Lisicki Robert EVP, Chief Commercial Officer | Arena Pharmaceuticals, Inc. (ARNA) | 03-Aug-21 | Market Option Sale (Planned) | 17,500 | $60.08 | $1,051,480.00 | (52%) 33.6K to 16.1K | |
| 05-Aug-21 6:08 PM View: | Lisicki Robert EVP, Chief Commercial Officer | Arena Pharmaceuticals, Inc. (ARNA) | 03-Aug-21 | Option Exercise | 17,500 | $40.95 | $716,625.00 | 109% 16.1K to 33.6K | |
| 15-Jun-21 5:27 PM View: | Dallas Jayson Donald Alexan... Director | Arena Pharmaceuticals, Inc. (ARNA) | 15-Jun-21 | Market Sale (Planned) | 1,223 | $66.36 | $81,158.30 | (15%) 8.38K to 7.15K | |
| 15-Jun-21 5:25 PM View: | Ouzren Nawal Director | Arena Pharmaceuticals, Inc. (ARNA) | 11-Jun-21 | Grant | 3,067 | -- | -- | 206% 1.49K to 4.55K | |
| 15-Jun-21 5:24 PM View: | Jarrett Jennifer Director | Arena Pharmaceuticals, Inc. (ARNA) | 11-Jun-21 | Grant | 3,067 | -- | -- | 38% 8.15K to 11.22K | |
| 15-Jun-21 5:26 PM View: | Fetzer Oliver Director | Arena Pharmaceuticals, Inc. (ARNA) | 11-Jun-21 | Grant | 3,067 | -- | -- | 46% 6.63K to 9.69K | |
| 15-Jun-21 5:22 PM View: | Neil Garry Arthur Director | Arena Pharmaceuticals, Inc. (ARNA) | 11-Jun-21 | Grant | 3,067 | -- | -- | 38% 8.15K to 11.22K | |
| 15-Jun-21 5:23 PM View: | Schoch Steven J Director | Arena Pharmaceuticals, Inc. (ARNA) | 11-Jun-21 | Grant | 4,600 | -- | -- | 100% 0 to 4.6K | |
| 15-Jun-21 5:24 PM View: | Nova Tina Susan Director | Arena Pharmaceuticals, Inc. (ARNA) | 11-Jun-21 | Grant | 3,067 | -- | -- | 19% 16.58K to 19.64K | |
| 15-Jun-21 5:27 PM View: | Gallahue Kieran Director | Arena Pharmaceuticals, Inc. (ARNA) | 11-Jun-21 | Grant | 3,067 | -- | -- | 31% 9.84K to 12.91K | |
| 15-Jun-21 5:27 PM View: | Dallas Jayson Donald Alexan... Director | Arena Pharmaceuticals, Inc. (ARNA) | 11-Jun-21 | Grant | 3,067 | -- | -- | 58% 5.31K to 8.38K | |
| 15-Jun-21 5:28 PM View: | Knobil Katharine Director | Arena Pharmaceuticals, Inc. (ARNA) | 11-Jun-21 | Grant | 3,067 | -- | -- | 82% 3.75K to 6.82K | |
| 02-Apr-21 8:10 PM View: | Stelzer Laurie EVP & Chief Financial Officer | Arena Pharmaceuticals, Inc. (ARNA) | 16-Mar-21 | Payment of Exercise | 4,356 | $76.10 | $331,492.00 | (23%) 19.26K to 14.9K | |
| 02-Apr-21 8:10 PM View: | Stelzer Laurie EVP & Chief Financial Officer | Arena Pharmaceuticals, Inc. (ARNA) | 16-Mar-21 | Option Exercise | 12,600 | -- | -- | 189% 6.66K to 19.26K | |
| 02-Apr-21 8:10 PM View: | Schmidt Joan EVP, General Counsel & Sec | Arena Pharmaceuticals, Inc. (ARNA) | 15-Mar-21 | Option Exercise | 12,600 | -- | -- | 183% 6.88K to 19.48K | |
| 02-Apr-21 8:10 PM View: | Schmidt Joan EVP, General Counsel & Sec | Arena Pharmaceuticals, Inc. (ARNA) | 15-Mar-21 | Payment of Exercise | 4,874 | $77.58 | $378,125.00 | (25%) 19.48K to 14.6K | |
| 03-Mar-21 9:32 PM View: | Munshi Amit President and CEO Director | Arena Pharmaceuticals, Inc. (ARNA) | 01-Mar-21 | Grant | 28,800 | -- | -- | 372% 7.75K to 36.55K | |
| 03-Mar-21 9:33 PM View: | Stelzer Laurie EVP & Chief Financial Officer | Arena Pharmaceuticals, Inc. (ARNA) | 01-Mar-21 | Grant | 6,660 | -- | -- | 100% 0 to 6.66K | |
| 03-Mar-21 9:37 PM View: | Schmidt Joan EVP, General Counsel & Sec | Arena Pharmaceuticals, Inc. (ARNA) | 01-Mar-21 | Grant | 6,660 | -- | -- | 3098% 0.21K to 6.88K | |
| 03-Mar-21 9:35 PM View: | Vincent Aurentz Executive VP and CBO | Arena Pharmaceuticals, Inc. (ARNA) | 01-Mar-21 | Grant | 6,660 | -- | -- | 25% 27.0K to 33.66K | |
| 03-Mar-21 9:36 PM View: | Lisicki Robert EVP, Chief Commercial Officer | Arena Pharmaceuticals, Inc. (ARNA) | 01-Mar-21 | Grant | 6,660 | -- | -- | 71% 9.44K to 16.1K | |
| 18-Feb-21 9:00 PM View: | Vincent Aurentz Executive VP and CBO | Arena Pharmaceuticals, Inc. (ARNA) | 16-Feb-21 | Market Option Sale (Planned) | 2,524 | $85.00 | $214,540.00 | (9%) 29.52K to 27.0K | |
| 18-Feb-21 9:00 PM View: | Vincent Aurentz Executive VP and CBO | Arena Pharmaceuticals, Inc. (ARNA) | 16-Feb-21 | Option Exercise | 2,524 | $14.80 | $37,354.40 | 9% 27.0K to 29.52K |
